Efficacy of the fully human anti-TNF antibody D2E7 in rheumatoid arthritis.

被引：0
|
作者：
van de Putte, BA
Rau, R
Breedveld, FC
Kalden, JR
Malaise, MG
Schattenkirchner, M
Emery, P
Burmester, GR
Zeidler, H
Moutsopoulos, HH
Compagnone, D
Kempeni, J
Kupper, H
机构：
来源：
ARTHRITIS AND RHEUMATISM | 1999年 / 42卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1977
引用
收藏
页码：S400 / S400
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)
    Sarzi-Puttini, P.
    Antivalle, M.
    Marchesoni, A.
    Favalli, E. G.
    Gorla, R.
    Filippini, M.
    Caporali, R.
    Bobbio-Pallavicini, F.
    Montecucco, C.
    Atzeni, F.
    REUMATISMO, 2008, 60 (04) : 290 - 295
  • [42] RHEUMATOID ARTHRITIS Obesity impairs efficacy of anti-TNF therapy in patients with RA
    Gonzalez-Gay, Miguel A.
    Gonzalez-Juanatey, Carlos
    NATURE REVIEWS RHEUMATOLOGY, 2012, 8 (11) : 641 - 642
  • [43] Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?
    Schwartzman, S
    Fleischmann, R
    Morgan, GJ
    ARTHRITIS RESEARCH & THERAPY, 2004, 6 (Suppl 2) : S3 - S11
  • [44] Long-term safety of fully human anti-TNF adalimumab in worldwide rheumatoid arthritis clinical trials
    Schiff, MH
    Burmester, GR
    Pangan, AL
    Kupper, H
    Spencer-Green, G
    Kent, JD
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S297 - S297
  • [45] Use of anti-TNF alpha drugs and incidence of hematologic and solid cancers in patients with rheumatoid arthritis.
    Setoguchi, S
    Solomon, DH
    Avorn, J
    Katz, JN
    Weinblatt, ME
    Glynn, RR
    Cook, EF
    Carney, G
    Schneeweiss, S
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S710 - S710
  • [46] Pharmacokinetics and safety of golimumab, a fully human anti-TNF-α monoclonal antibody, in subjects with rheumatoid arthritis
    Zhou, Honghui
    Jang, Haishan
    Fleischmann, Roy M.
    Bouman-Thio, Esther
    Xu, Zhenhua
    Marini, Joseph C.
    Pendley, Charles
    Jiao, Qun
    Shankar, Gopi
    Marciniak, Stanley J.
    Cohen, Stanley B.
    Rahman, Mahboob U.
    Baker, Daniel
    Mascelli, Mary Ann
    Davis, Hugh M.
    Everitt, Daniel E.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (03): : 383 - 396
  • [47] Adalimumab (D2E7), a fully human Anti-TNF-α monoclonal antibody, inhibits the progression of structural joint damage in patients with active RA despite concomitant methotrexate therapy.
    Keystone, E
    Kavanaugh, AF
    Sharp, J
    Hua, Y
    Teoh, L
    Fischkoff, S
    Chartash, E
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S205 - S205
  • [48] PAMAM dendrimers functionalised with an anti-TNF α antibody and chondroitin sulphate for treatment of rheumatoid arthritis
    Matos Oliveira, Isabel
    Goncalves, Cristiana
    Pinheiro Oliveira, Eduarda
    Simon-Vazquez, Rosana
    da Silva Morais, Alain
    Gonzalez-Fernandez, Africa
    Luis Reis, Rui
    Miguel Oliveira, Joaquim
    MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2021, 121
  • [49] CLINICAL COMPARISION OF EFFICACY AND SIDE EFFECT PROFILE OF RITUXIMAB AND ANTI-TNF IN RHEUMATOID ARTHRITIS
    Vagadia, Vipul
    RHEUMATOLOGY, 2010, 49 : I95 - I95
  • [50] Decreased T reg expression characterizes non-responders to anti-TNF therapy in rheumatoid arthritis.
    Posever, JO
    Kain, KJ
    Nordensson, K
    Ashrafzadeh, A
    Yocum, DE
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S137 - S137
12345